2019 novel-coronavirus: Cardiovascular insights about risk factors, myocardial injury, therapy and clinical implications
From December 31st, 2019, a novel highly pathogenic coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread worldwide, reaching at present the dimension of a pandemic. In addition to damaging the lungs, SARS-CoV-2 may also damage the heart and this is corroborated by th...
Enregistré dans:
Auteurs principaux: | Luigi Cappannoli, Roberto Scacciavillani, Giulia Iannaccone, Gianluca Anastasia, Federico Di Giusto, Valentina Loria, Nadia Aspromonte |
---|---|
Format: | article |
Langue: | EN |
Publié: |
KeAi Communications Co., Ltd.
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ee1065e9e7ef4c3dae9e5b007d6c215f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus
par: O. K. Vikulova, et autres
Publié: (2020) -
Reply to Siniorakis et al., “COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure”
par: David S. Fedson, et autres
Publié: (2020) -
Menores niveles tisulares de la enzima convertidora de angiotensina I homologa (ECA-2) y angiotensina-(1-9) están asociados a mayor remodelamiento de la pared aórtica de ratas hipertensas
par: Ocaranza,María Paz, et autres
Publié: (2010) -
Measurement of serum ACE status may potentially improve the diagnosis of SARS-CoV-2 infection
par: Gcinokwakhe D Ngcobo
Publié: (2021) -
Effect of Angiotensin Receptor Blocker and Angiotensin Converting Enzyme Inhibitor on Kidney Function and Blood Potassium Level in Indonesian Type 2 Diabetes Mellitus with Hypertension: A Three-Month Cohort Study
par: Puspita FM, et autres
Publié: (2021)